Overcoming Resistance And Toxicity Hurdles: PST's Localized Drug Delivery Technology May Unlock Combined MEK/Mtor ...
(MENAFN- PR Newswire) IRVINE, Calif., May 23, 2024 /PRNewswire/ -- Postsurgical Therapeutics, Inc. ( PST) today announced the successful completion of an in vivo study of its proprietary injectable gel formulation containing two drugs used to treat …